Daniel Leonard shared with us his views on key questions facing all organizations working in the gene therapy space, including:
– What’s the best strategy to engage with patients in the gene therapy space?
– How can you establish the patient advocacy function at your company?
– What are the main challenges unique to the gene therapy space?
Scoring a Therapeutic Bulls-Eye with Genetic Medicine Targeted to the CNS
Adapting Oncolytic Adenovirus Virotherapyfor Metastatic Neoplastic Disease
Intravitreal Gene Therapy for wet-AMD